Maaike C. Berkhout
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Maaike C. Berkhout has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
H.G.M. Heijerman
Department of Pulmonology, Haga Teaching Hospital, Leyweg 275, 2545 CH The Hague, The Netherlands
7 shared publications- E. Rijntjes4 shared publications
- L.H. el Bouazzaoui4 shared publications
W.J. Fokkens
Department of Otorhinolaryngology, Academic Medical Centre Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
3 shared publicationsC.J. van Rooden
Department of Radiology, Haga Teaching Hospital, Leyweg 275 2545 CH, The Hague, The Netherlands
2 shared publications- Daniel Johannes Touw
Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
2 shared publications
Latest Publications
- Open Access
- 26 August 2014
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 14 (3) , 412-413
Ivacaftor and sinonasal pathology in a cystic fibrosis patient with genotype deltaF508/S1215N
- 26 August 2014
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 14 (3) , 412-413
Open AccessIvacaftor and sinonasal pathology in a cystic fibrosis patient with genotype deltaF508/S1215N
- Open Access
- 11 July 2014
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 69 (11) , 3112-3115
Systemic absorption of nasally administered tobramycin and colistin in patients with cystic fibrosis
In cystic fibrosis (CF) patients the paranasal sinuses can constitute a niche for bacteria, which can migrate to the lungs. Nasal administration of antibiotics may be effective, but safety of this treatment has to be established first. The objective of this study was to investigate the systemic absorption of nasally administered tobramycin, colistin (administered as colistin sulfomethate sodium; CMS) and a combination of both drugs using systemic absorption as surrogate for safety. In addition, tolerability of the nasal irrigations was examined. Ten adult CF patients performed three different nasal irrigations: 300 mg of tobramycin; 160 mg of CMS; and 300 mg of tobramycin combined with 160 mg of CMS. Serum concentrations of tobramycin and colistin A and B (the main components of colistin) were analysed. Tolerability was measured using a visual analogue scale. Dutch Trial Register: NTR 4008. Following the tobramycin and the combined irrigation, only two patients had detectable tobramycin serum levels, with the highest being 0.054 mg/L. Serum levels of colistin A and B were not detectable. All three nasal irrigation solutions were well tolerated with a higher tolerability for CMS compared with tobramycin. Nasal irrigations with tobramycin, CMS and a combination of tobramycin and CMS resulted in safe serum levels and were well tolerated.
- 11 July 2014
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 69 (11) , 3112-3115
Open AccessSystemic absorption of nasally administered tobramycin and colistin in patients with cystic fibrosis
In cystic fibrosis (CF) patients the paranasal sinuses can constitute a niche for bacteria, which can migrate to the lungs. Nasal administration of antibiotics may be effective, but safety of this treatment has to be established first. The objective of this study was to investigate the systemic absorption of nasally administered tobramycin, colistin (administered as colistin sulfomethate sodium; CMS) and a combination of both drugs using systemic absorption as surrogate for safety. In addition, tolerability of the nasal irrigations was examined. Ten adult CF patients performed three different nasal irrigations: 300 mg of tobramycin; 160 mg of CMS; and 300 mg of tobramycin combined with 160 mg of CMS. Serum concentrations of tobramycin and colistin A and B (the main components of colistin) were analysed. Tolerability was measured using a visual analogue scale. Dutch Trial Register: NTR 4008. Following the tobramycin and the combined irrigation, only two patients had detectable tobramycin serum levels, with the highest being 0.054 mg/L. Serum levels of colistin A and B were not detectable. All three nasal irrigation solutions were well tolerated with a higher tolerability for CMS compared with tobramycin. Nasal irrigations with tobramycin, CMS and a combination of tobramycin and CMS resulted in safe serum levels and were well tolerated.
- 1 July 2014
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 13 (4) , 442-448
Sinonasal manifestations of cystic fibrosis: A correlation between genotype and phenotype?
- 1 July 2014
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 13 (4) , 442-448
Sinonasal manifestations of cystic fibrosis: A correlation between genotype and phenotype?
- 27 December 2013
- Published by Wiley in The Laryngoscope
- Vol. 124 (7) , 1682-1686
Temporal bone pneumatization in cystic fibrosis: A correlation with genotype?
Objectives/Hypothesis: Paranasal sinus pneumatization in patients with cystic fibrosis (CF) is less extensive compared to the general population and seems to be correlated to CF genotype. Interestingly, in CF patients temporal bone pneumatization (TBP) is more extensive compared to the general population, and middle ear pathology is generally uncommon in CF. It is debated whether TBP is influenced environmentally or genetically. The aim of the present study was to investigate pneumatization of the temporal bone in patients with CF and to correlate this with genotype and paranasal sinus volume.Study Design: Prospective collection of data.Methods: In 104 adult CF patients, computed tomography of the temporal bone and the paranasal sinuses was performed. TBP was graded using a validated scoring system. Patients were divided into two groups, mild and severe CF, based on their mutations in the CF transmembrane conductance regulator gene.Results: Of the 31 patients with mild CF, 71% had extensive TBP, and of the 73 patients with severe CF, 82% had extensive pneumatization of the temporal bone. TBP did not differ significantly for CF genotype, and TBP was not correlated to paranasal sinus volume.Conclusions: Whereas paranasal sinus pneumatization in CF patients seems to be related to CF genotype among other influencing factors, this study showed no correlation between TBP and CF genotype. TBP was not correlated to paranasal sinus volume. Hypothetically, in CF, pneumatization of the temporal bone is under a different influence than paranasal sinus pneumatization.Level of Evidence: 4 Laryngoscope, 124:1682–1686, 2014
- 27 December 2013
- Published by Wiley in The Laryngoscope
- Vol. 124 (7) , 1682-1686
Temporal bone pneumatization in cystic fibrosis: A correlation with genotype?
Objectives/Hypothesis: Paranasal sinus pneumatization in patients with cystic fibrosis (CF) is less extensive compared to the general population and seems to be correlated to CF genotype. Interestingly, in CF patients temporal bone pneumatization (TBP) is more extensive compared to the general population, and middle ear pathology is generally uncommon in CF. It is debated whether TBP is influenced environmentally or genetically. The aim of the present study was to investigate pneumatization of the temporal bone in patients with CF and to correlate this with genotype and paranasal sinus volume.Study Design: Prospective collection of data.Methods: In 104 adult CF patients, computed tomography of the temporal bone and the paranasal sinuses was performed. TBP was graded using a validated scoring system. Patients were divided into two groups, mild and severe CF, based on their mutations in the CF transmembrane conductance regulator gene.Results: Of the 31 patients with mild CF, 71% had extensive TBP, and of the 73 patients with severe CF, 82% had extensive pneumatization of the temporal bone. TBP did not differ significantly for CF genotype, and TBP was not correlated to paranasal sinus volume.Conclusions: Whereas paranasal sinus pneumatization in CF patients seems to be related to CF genotype among other influencing factors, this study showed no correlation between TBP and CF genotype. TBP was not correlated to paranasal sinus volume. Hypothetically, in CF, pneumatization of the temporal bone is under a different influence than paranasal sinus pneumatization.Level of Evidence: 4 Laryngoscope, 124:1682–1686, 2014
- 1 September 2013
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 12 (5) , 525-529
Importance of bacteriology in upper airways of patients with Cystic Fibrosis
- 1 September 2013
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 12 (5) , 525-529
Importance of bacteriology in upper airways of patients with Cystic Fibrosis
- 30 June 2013
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 12, S66
71 Pharmacokinetics of nasal administered tobramycin in patients with cystic fibrosis
- 30 June 2013
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 12, S66
71 Pharmacokinetics of nasal administered tobramycin in patients with cystic fibrosis
- 30 June 2013
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 12, S58
41 Nasal airway resistance in adult patients with cystic fibrosis
- 30 June 2013
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 12, S58
41 Nasal airway resistance in adult patients with cystic fibrosis
- 1 June 2012
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 11, S53
WS24.1 Sinonasal pathology in adult patients with cystic fibrosis
- 1 June 2012
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 11, S53
WS24.1 Sinonasal pathology in adult patients with cystic fibrosis
- 1 June 2012
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 11, S41
WS18.1 Failure of eradication therapy of Pseudomonas aeruginosa in cystic fibrosis: watch the nose
- 1 June 2012
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 11, S41
WS18.1 Failure of eradication therapy of Pseudomonas aeruginosa in cystic fibrosis: watch the nose